Home | Welcome to Contract Pharma   
Last Updated Thursday, November 20 2014
Print

Search Results for 'Financial Report: AMRI 3Q'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published October 28, 2014
Restructuring to decrease facilities footprint by 23% and a 20% reduction in staff by the end of 2015 Read More »
Published October 28, 2014
Generic competition, termination of Enbrel, Spiriva alliances impact results Read More »
Published October 28, 2014
Revenue up 4% in the quarter Read More »
Published October 14, 2014
Pharmaceutical sales up 18% in the quarter, new products drive growth Read More »
Published October 7, 2014
Invests in humidity controlled blister packaging Read More »
Published April 16, 2014
Will transition DDS ops to other sites Read More »
Published October 16, 2013
Luther brings extensive discovery experience Read More »
GDUFA Update
By Gil Y. Roth, Contract Pharma
Published January 22, 2013
A preview of our upcoming GDUFA & CMOs article Read More »
By Michael Martorelli
Published November 6, 2009
Feel Better Now? Ending one year, approaching the next By Michael A. Martorelli It’s always interesting to write a column about an event that is still in my future, but will have already happened by the time you read my words. Th… Read More »
Published September 10, 2007
AMRI opened its new 50,000-sq.-ft. R&D center at the Shapoorji Pallonji Biotech Park in Hyderabad, India. The new facility will provide additional space for the company's laboratory-scale operations in India. The new facility includes labs… Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On